Vetter President of Development Services USA joins iBIO board Vetter President of Development Services USA joins iBIO board Claudia Roth will offer her leadership and expertise in aseptic filling NextPharma makes three senior appointments NextPharma makes three senior appointments For liquids, pencilllins and regulatory affairs parts of the business Novasep complete its executive team Novasep complete its executive team Thierry Van Nieuwenhove joins the firm as President of the Synthesis Business Unit Changes at the top of the European Fine Chemicals Group Changes at the top of the European Fine Chemicals Group Appoints President, Vice President and Sector Group Manager Mitchell Reff becomes Chief Biologics Officer at ShangPharma Mitchell Reff becomes Chief Biologics Officer at ShangPharma He brings more than 30 years of reaearch experience to the position Novavax makes management promotions to support expanded clinical activity in 2014 Novavax makes management promotions to support expanded clinical activity in 2014 In preparation for expanded clinical trial activities over the next two years AMRI makes two leadership appointments AMRI makes two leadership appointments George Svokos joins as SVP Sales and General Manager, API while Vijay Kumar Batra becomes MD of AMRI India Jeffrey Chodakewitz to join Vertex as Chief Medical Officer Jeffrey Chodakewitz to join Vertex as Chief Medical Officer Will also be Senior Vice President of Global Medicines Development Actavis appoints new managers for its US Specialty Brands business Actavis appoints new managers for its US Specialty Brands business Four divisions will be women’s health, urology/gastroenterology, dermatology/established brands and business operations Galderma announces CEO for North American Operations Galderma announces CEO for North American Operations Stuart Raetzman will join the dermatology firm on 1 March Priaxon appoints Dr Constance Hoefer as Chief Development Officer Priaxon appoints Dr Constance Hoefer as Chief Development Officer Brings the necessary experience and knowledge for the Company to successfully advance Priaxon AG’s non-clinical programs towards the clinic Tim Tasker joins Heptares as Chief Medical Officer Tim Tasker joins Heptares as Chief Medical Officer Increases focus on clinical development of GPCR-targeted drug candidates Thomas Broeer elected as new BGMA Chairman Thomas Broeer elected as new BGMA Chairman Brings more than 20 years of industry experience to the position KaloBios hires Harry Lam as Head of Manufacturing KaloBios hires Harry Lam as Head of Manufacturing He joins the firm with more than 28 years of biopharmaceutical manufacturing experience Chris Kilbee appointed Group Director of UBM Pharma Portfolio Chris Kilbee appointed Group Director of UBM Pharma Portfolio Aims to expand the portfolio globally, putting increased emphasis on digital and content SCM Pharma appoints US business development manager SCM Pharma appoints US business development manager Derek Richards takes up the role